Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,250 publicly listed stocks with a combined market cap of $1.90 Trillion. Arbutus Biopharma Corp leads the sector with a market cap of $840.56 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.90 Trillion
Companies Listed
1,250
Largest Company
Arbutus Biopharma Corp
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 301 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
$840.56 Million | $840.56 Million | USA | $4.32 | +2.86% | +1.65% | 47.40 Million |
| 302 |
Blue Jet Healthcare Limited
NSE:BLUEJET |
$833.96 Million | Rs77.11 Billion | India | Rs444.55 | -0.29% | +6.65% | 12.82 Million |
| 303 |
Annexon Inc
NASDAQ:ANNX |
$833.22 Million | $833.22 Million | USA | $5.75 | -2.04% | -5.12% | 56.79 Million |
| 304 |
Sana Biotechnology Inc
NASDAQ:SANA |
$832.62 Million | $832.62 Million | USA | $3.27 | -0.61% | -4.94% | 81.44 Million |
| 305 |
DNA Link Inc
KQ:127120 |
$830.39 Million | ₩1.23 Trillion | Korea | ₩40800.00 | -0.73% | -3.66% | 4.29 Million |
| 306 |
Theravance Biopharma Inc
F:0TB |
$828.57 Million | €708.72 Million | Germany | €14.10 | -0.70% | +0.71% | 1.29K |
| 307 |
Xencor Inc
NASDAQ:XNCR |
$827.65 Million | $827.65 Million | USA | $12.69 | +6.37% | +1.93% | 18.64 Million |
| 308 |
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590 |
$823.70 Million | CN¥5.63 Billion | China | CN¥35.40 | -2.37% | -5.30% | 71.72 Million |
| 309 |
Gubra A/S
CO:GUBRA |
$820.85 Million | Dkr5.25 Billion | Denmark | Dkr321.00 | +1.13% | -2.01% | 693.07K |
| 310 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
$820.37 Million | $820.37 Million | USA | $26.65 | -0.04% | +39.68% | 110.86 Million |
| 311 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
$813.24 Million | $813.24 Million | USA | $8.56 | +3.63% | +3.13% | 36.31 Million |
| 312 |
Oneness Biotech Co Ltd
TWO:4743 |
$801.88 Million | NT$25.45 Billion | Taiwan | NT$53.20 | +2.70% | +0.57% | 43.51 Million |
| 313 |
Relmada Therapeutics Inc
NASDAQ:RLMD |
$798.21 Million | $798.21 Million | USA | $7.64 | +1.60% | +5.38% | 32.34 Million |
| 314 |
Janux Therapeutics Inc
NASDAQ:JANX |
$790.34 Million | $790.34 Million | USA | $14.34 | -0.21% | -5.60% | 23.09 Million |
| 315 |
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871 |
$778.09 Million | CN¥5.32 Billion | China | CN¥26.28 | -1.39% | -3.81% | 284.69 Million |
| 316 |
Kura Oncology Inc
NASDAQ:KURA |
$774.65 Million | $774.65 Million | USA | $8.77 | -0.68% | -5.39% | 32.60 Million |
| 317 |
Seegene Inc
KQ:096530 |
$767.20 Million | ₩1.13 Trillion | Korea | ₩24550.00 | -2.00% | -1.21% | 7.11 Million |
| 318 |
Clarity Pharmaceuticals Ltd
AU:CU6 |
$763.38 Million | AU$1.08 Billion | Australia | AU$2.90 | +2.47% | -2.03% | 60.67 Million |
| 319 |
PHARMING GRP SP. ADRS
F:PHG |
$762.66 Million | €652.34 Million | Germany | €13.90 | -0.71% | -4.79% | 447.00 |
| 320 |
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
$762.42 Million | CN¥5.21 Billion | China | CN¥34.89 | -2.87% | -3.24% | 40.60 Million |
| 321 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
$760.71 Million | $760.71 Million | USA | $9.41 | +2.06% | +0.97% | 25.93 Million |
| 322 |
Idorsia Ltd
SW:IDIA |
$759.27 Million | CHF600.56 Million | Switzerland | CHF3.68 | +1.60% | -2.59% | 37.60 Million |
| 323 |
Jiangsu Bioperfectus Technologies Co Ltd
SHG:688399 |
$757.86 Million | CN¥5.18 Billion | China | CN¥61.75 | +1.73% | -0.72% | 34.92 Million |
| 324 |
GH RESEARCH PLC DL-025
F:1KA |
$737.24 Million | €630.60 Million | Germany | €15.90 | -4.22% | -7.56% | 517.00 |
| 325 |
Pharmicell
KO:005690 |
$736.42 Million | ₩1.09 Trillion | Korea | ₩18110.00 | -8.40% | +1.91% | 27.97 Million |
| 326 |
ChemPartner PharmaTech Co Ltd
SHE:300149 |
$727.95 Million | CN¥4.97 Billion | China | CN¥9.99 | -0.10% | -8.85% | 910.95 Million |
| 327 |
Gyre Therapeutics Inc.
NASDAQ:GYRE |
$727.32 Million | $727.32 Million | USA | $7.80 | +1.56% | +4.84% | 1.41 Million |
| 328 |
Astria Therapeutics Inc
NASDAQ:ATXS |
$718.13 Million | $718.13 Million | USA | $5873.65 | +10.87% | +47002.25% | 16.63 Million |
| 329 |
Alto Neuroscience, Inc.
NYSE:ANRO |
$715.58 Million | $715.58 Million | USA | $24.94 | -2.81% | -2.99% | 7.65 Million |
| 330 |
BIOCYTOGEN PHARMA. H YC1
F:I54 |
$710.19 Million | €607.46 Million | Germany | €5.65 | +4.63% | -5.83% | 460.00 |
| 331 |
CytomX Therapeutics Inc
NASDAQ:CTMX |
$708.24 Million | $708.24 Million | USA | $4.18 | -0.95% | -6.07% | 93.96 Million |
| 332 |
Bright Minds Biosciences Inc
NASDAQ:DRUG |
$707.12 Million | $707.12 Million | USA | $86.96 | -1.13% | -1.94% | 4.38 Million |
| 333 |
Cullinan Oncology LLC
NASDAQ:CGEM |
$706.55 Million | $706.55 Million | USA | $13.43 | +2.91% | +3.71% | 16.35 Million |
| 334 |
Basilea Pharmaceutica AG
SW:BSLN |
$699.48 Million | CHF553.27 Million | Switzerland | CHF54.40 | +2.06% | -0.18% | 701.45K |
| 335 |
Assure Tech Hangzhou Co Ltd
SHG:688075 |
$695.87 Million | CN¥4.76 Billion | China | CN¥37.42 | -0.43% | -2.04% | 13.03 Million |
| 336 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
$690.60 Million | $690.60 Million | USA | $1.63 | +1.24% | -2.98% | 46.24 Million |
| 337 |
Beijing Scitop Bio Tech Co Ltd
SHE:300858 |
$688.25 Million | CN¥4.70 Billion | China | CN¥17.85 | -2.41% | -20.60% | 611.03 Million |
| 338 |
Vor Biopharma Inc
NASDAQ:VOR |
$676.54 Million | $676.54 Million | USA | $13.85 | -3.35% | -5.27% | 28.47 Million |
| 339 |
Arvinas Inc
NASDAQ:ARVN |
$672.23 Million | $672.23 Million | USA | $10.51 | +6.16% | +0.86% | 19.34 Million |
| 340 |
BridgeBio Oncology Therapeutics, Inc.
NASDAQ:BBOT |
$671.48 Million | $671.48 Million | USA | $8.39 | -0.24% | -6.47% | 10.98 Million |
| 341 |
Beijing Bohui Innovation Technology Co Ltd
SHE:300318 |
$669.41 Million | CN¥4.57 Billion | China | CN¥5.60 | -0.53% | -0.36% | 185.91 Million |
| 342 |
Sunmax Biotechnology Co Ltd
TWO:4728 |
$664.90 Million | NT$21.10 Billion | Taiwan | NT$387.50 | +0.00% | -1.15% | 339.42K |
| 343 |
Sinovac Biotech Ltd
NASDAQ:SVA |
$642.44 Million | $642.44 Million | USA | $6.47 | +0.00% | +0.00% | 0.00 |
| 344 |
Hinova Pharmaceuticals Inc. A
SHG:688302 |
$637.52 Million | CN¥4.36 Billion | China | CN¥44.00 | +7.95% | -2.20% | 51.97 Million |
| 345 |
AbClon Inc
KQ:174900 |
$635.95 Million | ₩938.42 Billion | Korea | ₩49150.00 | -2.48% | +2.18% | 9.74 Million |
| 346 |
Hefei Lifeon Pharmaceutical Co Ltd
SHE:003020 |
$632.57 Million | CN¥4.32 Billion | China | CN¥22.73 | -0.70% | -5.41% | 48.90 Million |
| 347 |
EirGenix
TWO:6589 |
$632.48 Million | NT$20.08 Billion | Taiwan | NT$66.40 | +0.45% | +7.27% | 14.47 Million |
| 348 |
Alpha Tau Medical Ltd
NASDAQ:DRTS |
$614.75 Million | $614.75 Million | USA | $8.54 | +2.40% | +7.02% | 7.76 Million |
| 349 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
$611.31 Million | $611.31 Million | USA | $4.93 | -0.40% | +6.25% | 113.81 Million |
| 350 |
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404 |
$606.22 Million | CN¥4.14 Billion | China | CN¥10.74 | +1.42% | +3.87% | 308.51 Million |
| 351 |
Pulike Biological Engineering
SHG:603566 |
$606.16 Million | CN¥4.14 Billion | China | CN¥11.97 | -0.33% | -4.62% | 93.29 Million |
| 352 |
Wecome Pharmaceutical Co Ltd
SHE:300878 |
$605.54 Million | CN¥4.14 Billion | China | CN¥28.58 | +3.93% | +8.83% | 40.77 Million |
| 353 |
Supriya Lifescience Limited
NSE:SUPRIYA |
$604.83 Million | Rs55.93 Billion | India | Rs694.90 | -0.48% | +5.93% | 5.22 Million |
| 354 |
CorMedix Inc
NASDAQ:CRMD |
$597.22 Million | $597.22 Million | USA | $7.79 | +2.64% | +6.28% | 23.42 Million |
| 355 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
$595.69 Million | $595.69 Million | USA | $3.41 | -3.81% | -11.20% | 44.34 Million |
| 356 |
Opthea Ltd
AU:OPT |
$580.76 Million | AU$820.79 Million | Australia | AU$0.60 | +0.00% | +0.00% | 0.00 |
| 357 |
Baolingbao Biology Co Ltd
SHE:002286 |
$572.48 Million | CN¥3.91 Billion | China | CN¥10.28 | +1.08% | -0.29% | 189.35 Million |
| 358 |
Regulus Therapeutics Inc
NASDAQ:RGLS |
$564.95 Million | $564.95 Million | USA | $8.16 | +0.25% | +0.62% | 55.65 Million |
| 359 |
Qingdao Vland Biotech Co Ltd
SHG:603739 |
$557.24 Million | CN¥3.81 Billion | China | CN¥15.05 | +0.47% | +0.20% | 101.78 Million |
| 360 |
Guanhao Biotech Co Ltd
SHE:300238 |
$551.36 Million | CN¥3.77 Billion | China | CN¥14.21 | -1.52% | -4.89% | 158.80 Million |
| 361 |
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
$545.65 Million | $545.65 Million | USA | $29.06 | +3.90% | +2.18% | 4.75 Million |
| 362 |
MiMedx Group Inc
NASDAQ:MDXG |
$545.02 Million | $545.02 Million | USA | $3.68 | +9.52% | +9.85% | 41.23 Million |
| 363 |
Sage Therapeutics Inc
NASDAQ:SAGE |
$544.94 Million | $544.94 Million | USA | $8.68 | +0.00% | -1.03% | 85.42 Million |
| 364 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
$540.93 Million | $540.93 Million | USA | $3.73 | +1.36% | +8.12% | 42.82 Million |
| 365 |
SHANDONG BOAN BIOTECH.H 1
F:UJ9 |
$538.40 Million | €460.53 Million | Germany | €0.74 | +2.07% | +3.50% | 794.00 |
| 366 |
Shanghai Shen Lian Biomedical Corp
SHG:688098 |
$531.20 Million | CN¥3.63 Billion | China | CN¥8.84 | -1.01% | +1.84% | 206.03 Million |
| 367 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
$525.38 Million | $525.38 Million | USA | $29.40 | +1.73% | -4.30% | 7.97 Million |
| 368 |
PYC Therapeutics Ltd
AU:PYC |
$517.68 Million | AU$731.64 Million | Australia | AU$1.23 | -2.78% | -5.04% | 27.89 Million |
| 369 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
$516.25 Million | $516.25 Million | USA | $10.07 | -0.98% | -0.40% | 17.79 Million |
| 370 |
OPTHEA LTD (SP.ADR/8)
F:UKJ2 |
$512.99 Million | €438.79 Million | Germany | €3.00 | +0.00% | +0.00% | 0.00 |
| 371 |
Medigen Vaccine Biologics
TWO:6547 |
$511.14 Million | NT$16.22 Billion | Taiwan | NT$49.35 | +2.81% | +2.49% | 84.68 Million |
| 372 |
Upstream Bio, Inc.
NASDAQ:UPB |
$507.96 Million | $507.96 Million | USA | $9.40 | +2.40% | -2.08% | 14.26 Million |
| 373 |
Zhejiang Shouxiangu Pharm Co
SHG:603896 |
$507.08 Million | CN¥3.47 Billion | China | CN¥17.48 | +0.06% | -4.74% | 36.01 Million |
| 374 |
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
$497.26 Million | CN¥3.40 Billion | China | CN¥6.92 | -0.57% | +12.70% | 253.79 Million |
| 375 |
Beijing Kawin Technology Share-holding Co Ltd
SHG:688687 |
$494.29 Million | CN¥3.38 Billion | China | CN¥19.76 | -1.54% | -7.19% | 91.12 Million |
| 376 |
Verastem Inc
NASDAQ:VSTM |
$491.00 Million | $491.00 Million | USA | $5.84 | +6.96% | -6.26% | 49.26 Million |
| 377 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
$485.93 Million | $485.93 Million | USA | $20.83 | +5.58% | -11.74% | 2.03 Million |
| 378 |
enGene Holdings Inc. Common Stock
NASDAQ:ENGN |
$485.67 Million | $485.67 Million | USA | $7.25 | -0.28% | -10.93% | 8.45 Million |
| 379 |
Fulcrum Therapeutics Inc
NASDAQ:FULC |
$485.54 Million | $485.54 Million | USA | $7.36 | +3.23% | -8.91% | 21.84 Million |
| 380 |
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653 |
$483.33 Million | CN¥3.30 Billion | China | CN¥18.35 | -1.45% | -2.45% | 51.67 Million |
| 381 |
Prothena Corporation plc
NASDAQ:PRTA |
$482.32 Million | $482.32 Million | USA | $10.64 | -3.80% | -0.84% | 10.40 Million |
| 382 |
Solid Biosciences LLC
NASDAQ:SLDB |
$482.26 Million | $482.26 Million | USA | $7.13 | -1.79% | -13.26% | 23.29 Million |
| 383 |
ADC Therapeutics SA
NYSE:ADCT |
$474.45 Million | $474.45 Million | USA | $3.83 | +1.32% | -3.28% | 21.90 Million |
| 384 |
Shanghai Model Organisms Center Inc
SHG:688265 |
$472.31 Million | CN¥3.23 Billion | China | CN¥41.40 | -0.05% | -4.12% | 16.69 Million |
| 385 |
Medy-Tox Inc
KQ:086900 |
$470.35 Million | ₩694.06 Billion | Korea | ₩105500.00 | -2.85% | -1.68% | 815.13K |
| 386 |
Valneva SE
PA:VLA |
$469.65 Million | €401.72 Million | France | €2.31 | -0.69% | -2.94% | 27.65 Million |
| 387 |
Shenzhen Bioeasy Biotechnology Co. Ltd.
SHE:300942 |
$467.67 Million | CN¥3.20 Billion | China | CN¥7.89 | +0.00% | -4.83% | 168.15 Million |
| 388 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
$464.06 Million | $464.06 Million | USA | $9.09 | +2.48% | -5.41% | 16.84 Million |
| 389 |
Ocugen Inc
NASDAQ:OCGN |
$461.52 Million | $461.52 Million | USA | $1.80 | +4.05% | +7.78% | 138.32 Million |
| 390 |
Eupraxia Pharmaceuticals Inc. Common Stock
NASDAQ:EPRX |
$459.64 Million | $459.64 Million | USA | $7.89 | +1.15% | +8.83% | 3.96 Million |
| 391 |
I-Mab
NASDAQ:IMAB |
$456.45 Million | $456.45 Million | USA | $3.96 | -1.74% | +0.25% | 11.39 Million |
| 392 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
$448.68 Million | $448.68 Million | USA | $10.15 | +0.00% | -0.49% | 35.55 Million |
| 393 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
$444.57 Million | $444.57 Million | USA | $5.58 | +1.27% | +1.09% | 7.11 Million |
| 394 |
Nanhua Bio Medicine Co Ltd
SHE:000504 |
$443.33 Million | CN¥3.03 Billion | China | CN¥9.18 | -3.27% | -5.36% | 70.82 Million |
| 395 |
Viva Biotech Holdings
F:VB0 |
$439.02 Million | €375.52 Million | Germany | €0.18 | +0.56% | -4.30% | 2.00K |
| 396 |
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
$438.41 Million | CN¥3.00 Billion | China | CN¥2.91 | +1.04% | -1.02% | 312.63 Million |
| 397 |
OPTHEA LTD
F:UKJ |
$437.75 Million | €374.43 Million | Germany | €0.32 | +0.00% | +0.00% | 0.00 |
| 398 |
VALNEVA SE SP.ADS/2
F:AYJ0 |
$435.54 Million | €372.54 Million | Germany | €4.54 | +0.00% | -2.99% | 213.00 |
| 399 |
Assembly Biosciences Inc
NASDAQ:ASMB |
$432.92 Million | $432.92 Million | USA | $27.37 | +1.56% | -3.39% | 2.31 Million |
| 400 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
$432.74 Million | $432.74 Million | USA | $8.87 | +0.80% | -0.89% | 27.64 Million |
| 401 |
Design Therapeutics Inc
NASDAQ:DSGN |
$430.65 Million | $430.65 Million | USA | $13.30 | -2.21% | +4.07% | 11.23 Million |
| 402 |
Zota Health Care LImited
NSE:ZOTA |
$430.12 Million | Rs39.77 Billion | India | Rs1311.20 | -0.09% | -0.18% | 1.28 Million |
| 403 |
Invivyd Inc.
NASDAQ:IVVD |
$428.62 Million | $428.62 Million | USA | $1.52 | +8.57% | +0.66% | 77.74 Million |
| 404 |
TaiMed Biologics
TWO:4147 |
$425.63 Million | NT$13.51 Billion | Taiwan | NT$49.45 | +0.10% | -2.47% | 31.74 Million |
| 405 |
Climb Bio Inc
NASDAQ:CLYM |
$425.61 Million | $425.61 Million | USA | $8.91 | +0.34% | -1.22% | 17.43 Million |
| 406 |
Green Cross
KO:005250 |
$425.10 Million | ₩627.28 Billion | Korea | ₩13960.00 | +0.43% | -2.58% | 2.31 Million |
| 407 |
PureTech Health PLC
NASDAQ:PRTC |
$421.98 Million | $421.98 Million | USA | $18.14 | +5.16% | +2.14% | 187.58K |
| 408 |
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO |
$421.14 Million | $421.14 Million | USA | $5.77 | +1.32% | -3.99% | 22.93 Million |
| 409 |
DBV Technologies S.A.
PA:DBV |
$420.88 Million | €360.00 Million | France | €3.63 | +1.06% | +8.29% | 21.89 Million |
| 410 |
Benitec Biopharma Ltd ADR
NASDAQ:BNTC |
$420.65 Million | $420.65 Million | USA | $12.70 | -2.01% | -6.62% | 3.18 Million |
| 411 |
Shandong Sito Bio-technology Co Ltd
SHE:300583 |
$419.72 Million | CN¥2.87 Billion | China | CN¥15.12 | +1.96% | +10.04% | 72.62 Million |
| 412 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
$414.65 Million | $414.65 Million | USA | $2.44 | -1.21% | +9.42% | 37.14 Million |
| 413 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
$408.15 Million | $408.15 Million | USA | $3.94 | -2.96% | -12.44% | 32.58 Million |
| 414 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
$404.82 Million | $404.82 Million | USA | $14.35 | +3.31% | +7.49% | 2.89 Million |
| 415 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
$404.51 Million | $404.51 Million | USA | $2.15 | +0.94% | -8.51% | 360.35 Million |
| 416 |
Regenxbio Inc
NASDAQ:RGNX |
$404.48 Million | $404.48 Million | USA | $9.12 | +1.67% | +1.45% | 13.19 Million |
| 417 |
Jilin Jian Yisheng Pharmaceutical Co Ltd
SHE:002566 |
$403.41 Million | CN¥2.76 Billion | China | CN¥8.33 | +0.48% | +8.89% | 187.67 Million |
| 418 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
$403.21 Million | $403.21 Million | USA | $14.50 | +7.41% | +13.19% | 4.36 Million |
| 419 |
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258 |
$402.43 Million | CN¥2.75 Billion | China | CN¥30.00 | +0.40% | -6.72% | 27.75 Million |
| 420 |
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM |
$401.89 Million | $401.89 Million | USA | $13.20 | +2.96% | +6.28% | 6.20 Million |
| 421 |
Genfit S.A.
PA:GNFT |
$399.59 Million | €341.79 Million | France | €8.08 | +2.67% | -8.70% | 6.65 Million |
| 422 |
Ginkgo Bioworks Holdings
NYSE:DNA |
$396.32 Million | $396.32 Million | USA | $9.70 | +14.66% | +25.97% | 27.14 Million |
| 423 |
Cabio Biotech Wuhan Co Ltd
SHG:688089 |
$394.80 Million | CN¥2.70 Billion | China | CN¥16.03 | -0.19% | -19.93% | 84.04 Million |
| 424 |
Eupraxia Pharmaceuticals Inc
TO:EPRX |
$393.86 Million | CA$544.47 Million | Canada | CA$10.75 | +0.94% | +7.61% | 1.33 Million |
| 425 |
Y mAbs Therapeutics
NASDAQ:YMAB |
$391.22 Million | $391.22 Million | USA | $8.61 | +0.23% | +0.35% | 21.23 Million |
| 426 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
$388.57 Million | $388.57 Million | USA | $1.47 | +4.26% | -3.92% | 33.86 Million |
| 427 |
Immix Biopharma Inc
NASDAQ:IMMX |
$388.16 Million | $388.16 Million | USA | $9.30 | +4.14% | -8.55% | 16.51 Million |
| 428 |
Niagen Bioscience, Inc.
NASDAQ:NAGE |
$387.06 Million | $387.06 Million | USA | $4.85 | +2.54% | +2.54% | 15.36 Million |
| 429 |
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
$385.27 Million | $385.27 Million | USA | $3.56 | +2.30% | -3.26% | 64.59 Million |
| 430 |
Puma Biotechnology Inc
NASDAQ:PBYI |
$381.06 Million | $381.06 Million | USA | $7.49 | -0.27% | +1.22% | 6.27 Million |
| 431 |
NEWRON PHARMACEUT. EO-20
F:NP5 |
$379.22 Million | €324.37 Million | Germany | €16.25 | +13.64% | -7.41% | 100.00 |
| 432 |
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90 |
$377.48 Million | €322.88 Million | Germany | €11.60 | -3.33% | +17.77% | 490.00 |
| 433 |
Candel Therapeutics Inc
NASDAQ:CADL |
$375.76 Million | $375.76 Million | USA | $6.47 | +4.69% | -8.10% | 39.36 Million |
| 434 |
Vigil Neuroscience Inc
NASDAQ:VIGL |
$375.71 Million | $375.71 Million | USA | $8.05 | +0.00% | -0.12% | 23.19 Million |
| 435 |
Formycon AG
XETRA:FYB |
$373.79 Million | €319.73 Million | Germany | €18.10 | +1.23% | -1.09% | 253.76K |
| 436 |
Shanghai Hile Bio-tech
SHG:603718 |
$372.04 Million | CN¥2.54 Billion | China | CN¥3.90 | +0.00% | -2.01% | 375.89 Million |
| 437 |
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
$369.88 Million | €316.38 Million | Germany | €15.85 | -0.63% | -12.67% | 149.37K |
| 438 |
Checkpoint Therapeutics Inc
NASDAQ:CKPT |
$367.72 Million | $367.72 Million | USA | $4.26 | +0.71% | +2.40% | 40.94 Million |
| 439 |
Opus Genetics, Inc.
NASDAQ:IRD |
$365.71 Million | $365.71 Million | USA | $5.14 | +0.59% | -1.34% | 18.12 Million |
| 440 |
Newron Pharmaceuticals SpA
SW:NWRN |
$360.88 Million | CHF285.44 Million | Switzerland | CHF14.30 | -3.38% | -12.80% | 1.87 Million |
| 441 |
Guiyang Xintian Pharmaceutical Co Ltd
SHE:002873 |
$360.77 Million | CN¥2.47 Billion | China | CN¥10.10 | +2.85% | +6.09% | 434.62 Million |
| 442 |
Vanda Pharmaceuticals Inc
NASDAQ:VNDA |
$359.97 Million | $359.97 Million | USA | $7.00 | -1.41% | +4.63% | 25.40 Million |
| 443 |
Aura Biosciences Inc
NASDAQ:AURA |
$357.52 Million | $357.52 Million | USA | $7.01 | -0.57% | -3.44% | 7.21 Million |
| 444 |
Monopar Therapeutics Inc
NASDAQ:MNPR |
$355.85 Million | $355.85 Million | USA | $53.25 | +2.11% | +0.02% | 3.93 Million |
| 445 |
Aclaris Therapeutics Inc
NASDAQ:ACRS |
$353.21 Million | $353.21 Million | USA | $4.41 | +1.61% | -3.08% | 34.30 Million |
| 446 |
Altimmune Inc
NASDAQ:ALT |
$353.15 Million | $353.15 Million | USA | $2.82 | +8.46% | -2.42% | 109.66 Million |
| 447 |
Lineage Cell Therapeutics Inc
NYSE MKT:LCTX |
$352.40 Million | $352.40 Million | USA | $1.53 | +1.32% | -1.92% | 26.08 Million |
| 448 |
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL |
$350.92 Million | $350.92 Million | USA | $15.50 | +8.62% | +3.96% | 16.03 Million |
| 449 |
Keros Therapeutics Inc
NASDAQ:KROS |
$350.06 Million | $350.06 Million | USA | $11.49 | +3.33% | -0.61% | 8.02 Million |
| 450 |
Compass Therapeutics Inc.
NASDAQ:CMPX |
$348.61 Million | $348.61 Million | USA | $1.96 | +10.73% | -62.38% | 303.36 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries